JP2016539179A5 - - Google Patents

Download PDF

Info

Publication number
JP2016539179A5
JP2016539179A5 JP2016546873A JP2016546873A JP2016539179A5 JP 2016539179 A5 JP2016539179 A5 JP 2016539179A5 JP 2016546873 A JP2016546873 A JP 2016546873A JP 2016546873 A JP2016546873 A JP 2016546873A JP 2016539179 A5 JP2016539179 A5 JP 2016539179A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
pain
composition according
pharmaceutically acceptable
inflammation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016546873A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016539179A (ja
JP6426746B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/058685 external-priority patent/WO2015054008A1/en
Publication of JP2016539179A publication Critical patent/JP2016539179A/ja
Publication of JP2016539179A5 publication Critical patent/JP2016539179A5/ja
Application granted granted Critical
Publication of JP6426746B2 publication Critical patent/JP6426746B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016546873A 2013-10-07 2014-10-01 4−メチルスルホニル−2−ブテンニトリル及びその医薬上の使用 Active JP6426746B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361887776P 2013-10-07 2013-10-07
US61/887,776 2013-10-07
PCT/US2014/058685 WO2015054008A1 (en) 2013-10-07 2014-10-01 4-methylsulfonyl-2-butenenitrile and its pharmaceutical use

Publications (3)

Publication Number Publication Date
JP2016539179A JP2016539179A (ja) 2016-12-15
JP2016539179A5 true JP2016539179A5 (cg-RX-API-DMAC10.html) 2017-10-26
JP6426746B2 JP6426746B2 (ja) 2018-11-21

Family

ID=52813515

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016546873A Active JP6426746B2 (ja) 2013-10-07 2014-10-01 4−メチルスルホニル−2−ブテンニトリル及びその医薬上の使用

Country Status (4)

Country Link
EP (1) EP3055286A4 (cg-RX-API-DMAC10.html)
JP (1) JP6426746B2 (cg-RX-API-DMAC10.html)
CN (1) CN105683158A (cg-RX-API-DMAC10.html)
WO (1) WO2015054008A1 (cg-RX-API-DMAC10.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105828769A (zh) * 2013-12-20 2016-08-03 宝洁公司 具有改善的箍和贴合性的尿布

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3444175A (en) * 1966-11-09 1969-05-13 Merck & Co Inc Certain picolylmethyl sulfones
MX2013006708A (es) * 2010-12-15 2013-09-13 Olatec Ind Llc Composicion de 3-metanosulfonilpropionitrilo para el tratamiento de la inflamacion y el dolor.
KR102002664B1 (ko) * 2012-02-27 2019-07-23 오라텍 세라퓨틱스 엘엘씨 3-메틸술포닐프로피오니트릴의 제조 방법
WO2014043144A1 (en) * 2012-09-11 2014-03-20 Olatec Industries Llc Methods for treating inflammation and pain

Similar Documents

Publication Publication Date Title
JP2014503533A5 (cg-RX-API-DMAC10.html)
EA201800064A1 (ru) 1,1,1-трифтор-3-гидроксипропан-2-ил карбаматные производные и 1,1,1-трифтор-4-гидроксибутан-2-ил карбаматные производные в качестве ингибиторов magl
CN110248926A (zh) Lsd1抑制剂及其制备方法和应用
SG10201903474PA (en) New substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said new substituted indazoles, and use of said new substituted indazoles to produce drugs
JP2014114305A5 (cg-RX-API-DMAC10.html)
PE20130496A1 (es) Tratamiento de artritis por lupus usando laquinimod
KR20140030122A (ko) 염증 및 통증 치료용 3-메탄술포닐프로피오니트릴
UA109868C2 (ru) Соединения n-алкилтриазола как антагонисты лизофосфатидной кислоты (lpar)
PH12017501029A1 (en) Biaryl derivative as gpr120 agonist
JP2014218522A5 (cg-RX-API-DMAC10.html)
MY159816A (en) New co-crystals of agomelatine, a process for their preparation and pharmaceutical compositions containing them
JP2016511753A5 (cg-RX-API-DMAC10.html)
JPWO2019160057A5 (cg-RX-API-DMAC10.html)
MX2015016543A (es) Derivados de biarilo como agonistas de gpr120.
JP2013523623A5 (cg-RX-API-DMAC10.html)
BR112013030264A2 (pt) ácidos acéticos de benzociclohepteno
JP2016533331A5 (cg-RX-API-DMAC10.html)
JP2016538288A5 (cg-RX-API-DMAC10.html)
RU2020111694A (ru) Новые соли и твердые формы эсциталопрама
JP2016531878A5 (cg-RX-API-DMAC10.html)
CN103804234B (zh) α-甲基-(3,4-二甲氧基苯基)-α-氨基丙腈的合成方法
WO2015138276A3 (en) Retinoic acid receptor-related orphan receptor modulators and uses thereof
BR112015010512A2 (pt) derivados de carboxamida de 3-aminociclopentano
MX2014014817A (es) Compuestos para el tratamiento de inflamacion y dolor.
US10273203B2 (en) Deuterated 3-methanesulfonylpropionitrile